Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1. | Cells | 2023 | 36980241 | PubTator, text mining | PubMed |
| Control of TurboID-dependent biotinylation intensity in proximity ligation screens. | J Proteomics | 2023 | 36966971 | PubTator, text mining | PubMed |
| Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase. | Front Cell Dev Biol | 2023 | 36936693 | PubTator, text mining | PubMed |
| Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome. | Nat Commun | 2023 | 36932076 | PubTator, text mining | PubMed |
| IgSF11-mediated phosphorylation of pyruvate kinase M2 regulates osteoclast differentiation and prevents pathological bone loss. | Bone Res | 2023 | 36928396 | PubTator, text mining | PubMed |
| High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display. | Elife | 2023 | 36927728 | PubTator, text mining | PubMed |
| Controlling Ibrutinib's Conformations about Its Heterobiaryl Axis to Increase BTK Selectivity. | ACS Med Chem Lett | 2023 | 36923918 | PubTator, text mining | PubMed |
| Role of FcγRIII in the nasal cavity of BALB/c mice in the primary amebic meningoencephalitis protection model. | Parasitol Res | 2023 | 36913025 | PubTator, text mining | PubMed |
| Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology. | Arab J Chem | 2023 | 36910427 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. | Molecules | 2023 | 36903645 | PubTator, text mining | PubMed |
| The Role of Proteomics and Phosphoproteomics in the Discovery of Therapeutic Targets and Biomarkers in Acquired EGFR-TKI-Resistant Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 36902280 | PubTator, text mining | PubMed |
| Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphoma. | PLoS One | 2023 | 36888611 | PubTator, text mining | PubMed |
| Bioinformatics-based identification of lipid- and immune-related biomarkers in abdominal aortic aneurysms. | Heliyon | 2023 | 36879746 | PubTator, text mining | PubMed |
| FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis. | Front Oncol | 2023 | 36874106 | PubTator, text mining | PubMed |
| The link between rheumatic disorders and inborn errors of immunity. | EBioMedicine | 2023 | 36870198 | PubTator, text mining | PubMed |
| NEF-Induced HIV-Associated Nephropathy Through HCK/LYN Tyrosine Kinases. | Am J Pathol | 2023 | 36868467 | PubTator, text mining | PubMed |
| Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives. | Front Immunol | 2023 | 36865552 | PubTator, text mining | PubMed |
| Effect of radiative and nonradiative energy transfer processes of light-emitting diodes combined with quantum dots for visible light communication. | Discov Nano | 2023 | 36862206 | PubTator, text mining | PubMed |
| High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions. | MAbs | 2023 | 36859773 | PubTator, text mining | PubMed |
| Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets. | Kidney Blood Press Res | 2023 | 36854280 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=15